Karah Herdman Parschauer Insider Trading $RARE Ultragenyx Pharmaceutical Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Karah Herdman Parschauer.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Karah Herdman Parschauer. Karah Herdman Parschauer is EVP and General Counsel in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Evolus, Inc. ($EOLS) and Director in Arcturus Therapeutics Holdings Inc. ($ARCT).

Karah Herdman Parschauer in Ultragenyx Pharmaceutical Inc.

Trading Symbol: RARE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karah Herdman Parschauer: EVP and General Counsel
Holdings: 29,997 shares
Current Value: $2,187,081
Latest Transaction: May 10 2021
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Karah Herdman Parschauer in Ultragenyx Pharmaceutical Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARCT, EOLS, RARE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 10 2021RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS113.6731335,57929,99730.3 K to 30 K (-1.03 %)
Mar 03 2021RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Option ExerciseA142.4711,0001,567,17011,000
Mar 03 2021RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS138.173,970548,53530,22734.2 K to 30.2 K (-11.61 %)
Mar 03 2021RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...GrantA0.004,636034,19729.6 K to 34.2 K (+15.68 %)
Mar 03 2021RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...GrantA0.005,500029,56124.1 K to 29.6 K (+22.86 %)
Nov 02 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Option ExerciseM54.509,903539,71425,000
Nov 02 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS100.129,903991,48824,06134 K to 24.1 K (-29.16 %)
Nov 02 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...BuyM54.509,903539,71433,87124 K to 33.9 K (+41.32 %)
Oct 30 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Option ExerciseM54.50975,28734,903
Oct 30 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS100.00979,70023,96824.1 K to 24 K (-0.40 %)
Oct 30 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...BuyM54.50975,28724,06524 K to 24.1 K (+0.40 %)
Oct 16 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS88.0032528,60023,96824.3 K to 24 K (-1.34 %)
Oct 13 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Option ExerciseM54.5010,000545,00035,000
Oct 13 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS95.0010,000950,00024,29334.3 K to 24.3 K (-29.16 %)
Oct 13 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...BuyM54.5010,000545,00034,29324.3 K to 34.3 K (+41.16 %)
Oct 07 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Option ExerciseM48.4310,000484,30017,000
Oct 07 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS90.0010,000900,00024,29334.3 K to 24.3 K (-29.16 %)
Oct 07 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...BuyM48.4310,000484,30034,29324.3 K to 34.3 K (+41.16 %)
Sep 24 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Option ExerciseM48.4310,000484,30027,000
Sep 24 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS85.0010,000850,00024,29334.3 K to 24.3 K (-29.16 %)
Sep 24 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...BuyM48.4310,000484,30034,29324.3 K to 34.3 K (+41.16 %)
Aug 19 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Option ExerciseM54.5010,000545,00045,000
Aug 19 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS88.392,370209,48424,29326.7 K to 24.3 K (-8.89 %)
Aug 19 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS88.4410,000884,40026,66336.7 K to 26.7 K (-27.28 %)
Aug 19 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...BuyM54.5010,000545,00036,66326.7 K to 36.7 K (+37.51 %)
Jun 22 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Payment of ExerciseF78.2264950,76526,66327.3 K to 26.7 K (-2.38 %)
May 19 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS74.722,722203,37427,31230 K to 27.3 K (-9.06 %)
May 08 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Payment of ExerciseF66.2624816,43229,90430.2 K to 29.9 K (-0.82 %)
Apr 21 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Payment of ExerciseF58.5724814,52530,15230.4 K to 30.2 K (-0.82 %)
Mar 03 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Option ExerciseA56.0822,0001,233,76022,000
Mar 03 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Payment of ExerciseF56.082,118118,77730,40032.5 K to 30.4 K (-6.51 %)
Mar 03 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...GrantA0.005,634032,51826.9 K to 32.5 K (+20.96 %)
Mar 03 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...GrantA0.007,800026,88419.1 K to 26.9 K (+40.87 %)
Oct 16 2019RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...GrantA0.001,434019,08417.7 K to 19.1 K (+8.12 %)
Jun 24 2019RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS61.501,22675,39917,65018.9 K to 17.7 K (-6.50 %)
Jun 24 2019RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS63.011,48993,82218,87620.4 K to 18.9 K (-7.31 %)
Jun 24 2019RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Payment of ExerciseF63.4864941,19920,36521 K to 20.4 K (-3.09 %)
Jun 24 2019RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS61.501,22675,39917,65018.9 K to 17.7 K (-6.50 %)
Jun 24 2019RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS63.011,48993,82218,87620.4 K to 18.9 K (-7.31 %)
Jun 24 2019RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Payment of ExerciseF63.4864941,19920,36521 K to 20.4 K (-3.09 %)
May 07 2019RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...GrantA0.001,434021,01419.6 K to 21 K (+7.32 %)
Apr 30 2019RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS68.3046831,96419,58020 K to 19.6 K (-2.33 %)
Apr 23 2019RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Payment of ExerciseF64.4324815,97920,04820.3 K to 20 K (-1.22 %)
Aug 21 2018RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS78.535,000392,6509,18114.2 K to 9.2 K (-35.26 %)
Jun 21 2018RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS82.771,226101,47614,18115.4 K to 14.2 K (-7.96 %)
Jun 20 2018RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Payment of ExerciseF85.3164955,36615,40716.1 K to 15.4 K (-4.04 %)
May 10 2018RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS60.001,46587,90016,05617.5 K to 16.1 K (-8.36 %)
Apr 19 2018RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...GrantA0.001,431017,52116.1 K to 17.5 K (+8.89 %)
Jun 21 2017RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Payment of ExerciseF63.3870544,6838,7959.5 K to 8.8 K (-7.42 %)
Mar 01 2017RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Option ExerciseA88.8012,0001,065,60012,000
Mar 01 2017RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...GrantA0.002,00009,5007.5 K to 9.5 K (+26.67 %)
Jun 22 2016RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Option ExerciseA54.5060,0003,270,00060,000
Jun 22 2016RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...GrantA0.007,50007,5000 to 7.5 K

Page:   1